1. Home
  2. PEPG vs FISK Comparison

PEPG vs FISK Comparison

Compare PEPG & FISK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PEPG
  • FISK
  • Stock Information
  • Founded
  • PEPG 2018
  • FISK N/A
  • Country
  • PEPG United States
  • FISK
  • Employees
  • PEPG N/A
  • FISK 667
  • Industry
  • PEPG Biotechnology: Pharmaceutical Preparations
  • FISK
  • Sector
  • PEPG Health Care
  • FISK
  • Exchange
  • PEPG Nasdaq
  • FISK NYSE
  • Market Cap
  • PEPG 52.4M
  • FISK N/A
  • IPO Year
  • PEPG 2022
  • FISK N/A
  • Fundamental
  • Price
  • PEPG $1.46
  • FISK $7.42
  • Analyst Decision
  • PEPG Buy
  • FISK
  • Analyst Count
  • PEPG 3
  • FISK 0
  • Target Price
  • PEPG $7.67
  • FISK N/A
  • AVG Volume (30 Days)
  • PEPG 224.5K
  • FISK N/A
  • Earning Date
  • PEPG 05-08-2025
  • FISK N/A
  • Dividend Yield
  • PEPG N/A
  • FISK N/A
  • EPS Growth
  • PEPG N/A
  • FISK N/A
  • EPS
  • PEPG N/A
  • FISK N/A
  • Revenue
  • PEPG N/A
  • FISK N/A
  • Revenue This Year
  • PEPG N/A
  • FISK N/A
  • Revenue Next Year
  • PEPG N/A
  • FISK N/A
  • P/E Ratio
  • PEPG N/A
  • FISK N/A
  • Revenue Growth
  • PEPG N/A
  • FISK N/A
  • 52 Week Low
  • PEPG $0.88
  • FISK N/A
  • 52 Week High
  • PEPG $19.30
  • FISK N/A
  • Technical
  • Relative Strength Index (RSI)
  • PEPG 48.32
  • FISK 55.68
  • Support Level
  • PEPG $1.40
  • FISK $6.77
  • Resistance Level
  • PEPG $1.73
  • FISK $7.10
  • Average True Range (ATR)
  • PEPG 0.17
  • FISK 0.00
  • MACD
  • PEPG 0.01
  • FISK 0.04
  • Stochastic Oscillator
  • PEPG 32.50
  • FISK 100.00

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.

About FISK EMPIRE STATE REALTY OP LIM PARTNER

Empire State Realty OP LP is an NYC-focused real estate investment trust (REIT) that owns and operates a portfolio of well-leased, top-of-tier, modernized, amenitized, and well-located office, retail, and multifamily assets, conducts all of its business and owns substantially all of its assets. The firm operates in two segments, Real Estate and Observatory. Through the Real Estate segment, it offers services related to the ownership, management, operation, acquisition, repositioning and disposition of its real estate assets. Under the Observatory segment, it operates the two observatories of the Empire State Building. The company generates maximum revenue from the Real Estate segment.

Share on Social Networks: